An Iridociliochoroidal Myeloid Sarcoma Associated With Relapsed Acute Myeloid Leukemia With FLT3-ITD Mutation, Treated With Gilteritinib, an FLT3 Inhibitor.
Publication/Presentation Date
4-1-2020
Volume
138
Issue
4
First Page
418
Last Page
419
ISSN
2168-6173
Published In/Presented At
Kim, R. S., Yaghy, A., Wilde, L. R., & Shields, C. L. (2020). An Iridociliochoroidal Myeloid Sarcoma Associated With Relapsed Acute Myeloid Leukemia With FLT3-ITD Mutation, Treated With Gilteritinib, an FLT3 Inhibitor. JAMA ophthalmology, 138(4), 418–419. https://doi.org/10.1001/jamaophthalmol.2020.0110
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
32163103
Department(s)
Administration and Leadership
Document Type
Article
COinS